Hedge Fund Manager Kyle Bass Is Going After Big Pharma And Their 'BS Patents'
REUTERS/Brendan McDermidKyle Bass, founder and principal of Hayman Capital Management, L.P., speaks at the Sohn Investment Conference in New York, May 8, 2013. Texan hedge fund manager Kyle Bass is going activist against the U.S. pharmaceutical industry and their patents, according to @finansakrobat's Twitter feed.
"We'll have a separate pharmacy vehicle. We've dedicated half of our resources over the past six months to this," Bass told conference attendees.
Bass, the founder of Hayman Capital, was speaking at the Skagen New Year's Conference in Copenhagen.
Bass told conference attendees that he plans to file IPR petitions (inter partes reviews) to challenge drugmaker patents.
"This will change the way pharma companies [manage] their BS patents," Bass said, according to @finansakrobat.
We reached out to Hayman Capital for more on the presentation.
In the meantime, here's a great rundown courtesy of @finansakrobat's Twitter feed.
Next Story
I quit McKinsey after 1.5 years. I was making over $200k but my mental health was shattered.
Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
I tutor the children of some of Dubai's richest people. One of them paid me $3,000 to do his homework.
Why are so many elite coaches moving to Western countries?
Global GDP to face a 19% decline by 2050 due to climate change, study projects
5 things to keep in mind before taking a personal loan
Markets face heavy fluctuations; settle lower taking downtrend to 4th day
Move over Bollywood, audio shows are starting to enter the coveted ‘100 Crores Club’
